Toxicology Safety Assessment & Regulatory Submission Navigator
Verify toxicology submission readiness and navigate FDA/ICH regulatory pathways
What You Can Do
You can assess your complete toxicology data package against ICH guidelines and FDA submission standards, then receive a tailored compliance checklist based on your regulatory pathway (IND, NDA, BLA, ANDA, CTA, or IMPD). The skill identifies missing documentation, flags non-compliant safety summaries, and validates that your CTD module 2.3.7 sections meet agency expectations—helping you avoid Complete Response Letters and accelerate market entry.
Features
Input your product type and indication; receive guidance on whether IND, CTA, IMPD, NDA, BLA, or ANDA applies
Compare your toxicology package against ICH M3(R2), ICH M7, and FDA guidance documents to identify missing studies or data
Evaluate draft CTD 2.3.7.1 sections for completeness, format, and regulatory language standards
Generate a prioritized checklist of documentation, study reports, and summaries required for your specific pathway
Cross-reference your data package against age-appropriate safety pharmacology, ADME, and toxicology study requirements
Identify differences between US FDA, EMA, and PMDA requirements for simultaneous submissions
Systematically address regulatory agency feedback and re-assess compliance against original submission gaps
Example Output
Example 1: IND Submission Readiness
✓ Regulatory Pathway: IND (Investigational New Drug) — Phase 1 oncology indication
✓ Compliance Status: 8/10 sections complete
⚠ Missing Items:
- GLP-compliant 28-day repeat-dose toxicity study (rodent)
- Preliminary ADME/PK data in animal model
- Reproductive/developmental toxicity justification
Example 2: Safety Summary Draft Feedback
Your CTD 2.3.7.1 safety summary covers: ✓ Pharmacology ✓ Pharmacokinetics & metabolism ⚠ Toxicology: Missing target organ toxicity discussion ⚠ Human safety data: Not applicable (first-in-human)
Suggestion: Add organ-specific findings table and reference supporting study appendices.
Example 3: Multi-Region Submission Gaps
US FDA: Requires phototoxicity study (Type I photosensitizer suspected) EMA: Waives phototoxicity if in vitro data negative JapAN PMDA: Equivalent to FDA; phototoxicity required
Recommendation: Conduct phototoxicity study to align US/Japan requirements.
What's Included
- SKILL.md instruction file with regulatory framework and submission workflow:
- Regulatory Pathway Decision Tree: flowchart to select IND, CTA, IMPD, NDA, BLA, or ANDA
- ICH Compliance Checklist Template: itemized requirements for M3(R2), M7, safety pharmacology, and ADME
- CTD 2.3.7 Safety Summary Outline: section-by-section template with FDA/EMA language standards
- CRL Remediation Tracker: framework for systematically addressing agency feedback and re-submission planning
- Multi-Region Requirement Comparison Matrix: FDA vs. EMA vs. PMDA standards side-by-side
Who It's For
- Toxicologists preparing preclinical data packages for regulatory submission
- Regulatory Scientists and Regulatory Affairs Professionals managing IND, CTA, NDA, or BLA submissions
- Quality Assurance/Compliance leads verifying submission readiness before filing
- Preclinical Program Managers transitioning programs from R&D to regulatory
- Clinical Development teams responding to Complete Response Letters or agency requests
Best For
- IND, CTA, IMPD, NDA, BLA, and ANDA submission preparation
- Safety summary (CTD 2.3.7) drafting and validation
- Regulatory pathway selection and indication-specific compliance assessment
- Multi-region (US, EU, Japan) simultaneous submission strategy planning
- Post-CRL gap remediation and re-submission readiness verification
- Competitive benchmarking against approved therapeutics in your indication
You might also like
This skill generates comprehensive fault study reports, protection coordination analyses, and compliance documentation for electrical power systems. It systematically documents fault scenarios, relay settings, coordination curves, and technical specifications required for grid operations and regulatory compliance. You produce production-ready documentation that meets industry standards—IEEE, NERC, and regional RTO requirements.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
Analyze your PLC code and ladder logic to identify logic errors, safety violations, and inefficiencies before they reach production. You'll get detailed diagnostics of control system failures, safety compliance verification against IEC 61131 standards, and optimization recommendations for automation sequences. This skill helps you prevent costly downtime, ensure worker safety, and improve system performance across manufacturing operations.
by kody-w
Create comprehensive tool specifications tailored to your manufacturing process, material combinations, and performance requirements. Analyze cutting speeds, feeds, tool life, and thermal behavior to predict tool performance and identify optimization opportunities. You can compare design alternatives, predict failure modes, and generate compliance documentation for production tooling decisions.
by kody-w
You can prepare complete site monitoring visit documentation, including source document verification (SDV) checklists tailored to specific case report forms, comprehensive findings reports from visit notes, and structured data query forms for identified discrepancies. This skill standardizes compliance documentation, identifies protocol deviations systematically, and creates actionable remediation plans to maintain data integrity and GCP compliance across investigator sites.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
Systematically evaluate ingredient compatibility against your active pharmaceutical ingredients, predict formulation behavior and stability risks, and troubleshoot phase separation, incompatibility, and irritation issues in real time. Generate ICH-aligned stability protocols, excipient safety summaries, and regulatory-ready documentation that accelerates IND, NDA, and ANDA submissions without replacing lab validation.
by kody-w